MYASTERIX
Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis
| Coordinator | ACADEMISCH ZIEKENHUIS LEIDEN ; AEPODIA SA ; PICHEM FORSCHUNGS-UND ENTWICKLUNGSGMBH ; CURAVAC EUROPE SPRL ; INSERM TRANSFERT SA |
| Grant period | 2013-10-01 - 2018-09-30 |
| Funding body | European Union |
| Call number | FP7-HEALTH-2013-INNOVATION-1 |
| Grant number | 602420 |
| Identifier | G:(EU-Grant)602420 |